Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W24 AI medical record review for health insurance prior auth and claims; $3.1M from General Catalyst/DRW/YC deploying AI agents that process clinical documentation for coverage decisions competing with Cohere Health.
InQuery is a San Francisco-based AI healthcare platform — backed by Y Combinator (W24) with $3.1 million in total funding from Y Combinator, General Catalyst, Amino Capital, and DRW Venture Capital — providing health insurance companies and managed care organizations with AI agents that autonomously review medical records, analyze clinical documentation, and process prior authorization and claims decisions at a speed and scale that human reviewers cannot match. Founded in 2023, InQuery applies large language models trained on clinical documentation to the insurance review workflows that currently require teams of nurses and physician advisors to manually read through hundreds of pages of medical records per case.
Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.